Bell Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46K Hold
17
﹤0.01% 1442
2026
Q1
$1.54K Sell
17
-12
-41% -$1.1K ﹤0.01% 1416
2025
Q4
$2.61K Sell
29
-13
-31% -$1.23K ﹤0.01% 1252
2025
Q3
$4.14K Sell
42
-13
-24% -$1.29K ﹤0.01% 1023
2025
Q2
$5.02K Sell
55
-8
-13% -$774 ﹤0.01% 971
2025
Q1
$7.13K Sell
63
-10
-14% -$1.07K ﹤0.01% 742
2024
Q4
$7.71K Sell
73
-40
-35% -$4.29K ﹤0.01% 717
2024
Q3
$12.2K Sell
113
-13
-10% -$1.42K ﹤0.01% 547
2024
Q2
$13.7K Buy
126
+20
+19% +$2.36K ﹤0.01% 494
2024
Q1
$14K Sell
106
-7
-6% -$874 ﹤0.01% 468
2023
Q4
$13.8K Buy
113
+25
+28% +$2.79K ﹤0.01% 452
2023
Q3
$9.88K Sell
88
-18
-17% -$2.29K ﹤0.01% 508
2023
Q2
$15.4K Sell
106
-8
-7% -$1.09K ﹤0.01% 366
2023
Q1
$14.7K Buy
114
+22
+24% +$2.76K ﹤0.01% 379
2022
Q4
$11.7K Buy
92
+2
+2% +$232 ﹤0.01% 433
2022
Q3
$9K Buy
90
+51
+131% +$5.6K ﹤0.01% 462
2022
Q2
$4K Buy
+39
New +$4.63K ﹤0.01% 869
2021
Q4
$8K Buy
65
+31
+91% +$4.06K ﹤0.01% 582
2021
Q3
$5K Buy
+34
New +$5K ﹤0.01% 752

Other funds holding ZBH

Bell Investment Advisors's ZBH Position: Q2 2026 in Review

Bell Investment Advisors held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 17 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Bell Investment Advisors first reported a position in ZBH in Q3 2021 and has held it in 19 quarters since. The position peaked at $15.4K in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Bell Investment Advisors held 17 shares of Zimmer Biomet worth $1.46K as of Q2 2026.
  • Bell Investment Advisors left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1442 holding.
  • Bell Investment Advisors first reported a position in Zimmer Biomet in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Zimmer Biomet position peaked at $15.4K in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.